Latest return on equity
Relmada Therapeutics Return on equity
Direct answer
Relmada Therapeutics's return on equity is -55.66%.
The verified market snapshot reports -55.66%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 24, 2026.
Get free Relmada Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -55.66%
Explore related company data
View Relmada Therapeutics's market capitalizationView Relmada Therapeutics's price-to-book ratioView Relmada Therapeutics's dividend yieldView Relmada Therapeutics's 52-week price rangeView Relmada Therapeutics's profit marginView all Relmada Therapeutics key metricsReturn to Relmada Therapeutics profile